ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store? [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
Investors are advised to focus on the sales performance of the company's core business segments — rare disease and generic business. The Zacks Consensus Estimate for the company's earnings per share is currently pegged at 98 cents. The Zacks Consensus Estimate for total revenues is pinned at $125 million. Let's see how things might have shaped up for the upcoming quarterly release. Factors to Consider ANIP gains revenues primarily from the sales of its rare disease products, generics and established brand pharmaceutical products, royalties and other pharmaceutical services. The company's revenue growth in the first quarter is likely to have been primarily driven by the rapid uptake of its rare disease products, which include ANI Pharmaceuticals' lead asset, Cortrophin Gel. Higher revenues from Cortrophin Gel are likely to have boosted the company's top line in the to-be-reported quarter. The drug has shown growth in the number of new unique prescribers and repeat prescribe
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its price target raised by analysts at HC Wainwright from $83.00 to $87.00. They now have a "buy" rating on the stock.MarketBeat
- ANI Pharmaceuticals, Inc. Just Beat EPS By 459%: Here's What Analysts Think Will Happen Next [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- ANI (ANIP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]Yahoo! Finance
ANIP
Earnings
- 5/10/24 - Beat
ANIP
Sec Filings
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- 5/17/24 - Form 144
- ANIP's page on the SEC website